Abstract:Double strand breaks (DSBs) at specific loci can be efficiently induced by genome editing tools. It is believed that most DSBs are repaired by either non-homologous end joining (NHEJ) or homology directed repair (HDR) using synthetic DNA templates. Our study aims to evaluate if DNA DSBs in human preimplantation embryos also repaired by an alternative mechanism known as gene conversion (GC). Pre-tested sgRNAs and Cas9 protein were co-injected into human MII oocytes or zygotes to target heterozygous MYH7 (g.15819 C>T; NG_007884.1) and homozygous wild-type (WT) MYBPC3 (g.9836, NC_000011.10) loci. Injected embryos were cultured for 3 days and then individual blastomeres of cleaving embryos were isolated and analyzed by sequencing at a single-cell level. DNA from each individual blastomere was amplified and the target region was sequenced by Sanger. Since gene conversion results in loss of heterozygosity (LOH) around target region, we evaluated the presence or loss of single-nucleotide polymorphisms (SNPs) adjacent to the target region. As expected, most DSBs at the heterozygous MYH7 locus were repaired by NHEJ (58.3%; 70/120) resulting in additional indel mutations on the mutant allele. However, remaining 41.7% (50/120) of blastomeres lost the mutant allele and were presented by the WT allele. We excluded possibility of deletions in these samples abut showed LOH at adjacent loci. When targeting both alleles at homozygous MYBPC3 locus, we found that 40.2% (129/321) blastomeres appeared with identical indel mutations on both parental alleles, indicating that GC and NHEJ compete and interplay with each other within the same cell. In contrast, frequency of HDR via exogenous synthetic DNA templates is limited. We report here that in addition to NHEJ and HDR, human embryos frequently employ an alternative repair mechanism known as gene conversion where intact endogenous homologous sequences are used as templates. While gene conversion could be applicable for gene correction, extensive LOH presents a safety concern.

CRISPR/Cas9-mediated Gene Editing in Human Tripronuclear Zygotes

CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein

Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos

CRISPR: Established Editor of Human Embryos?

Development and application of CRISPR/Cas9 technologies in genomic editing.

Correction of a pathogenic gene mutation in human embryos

Efficient Repair of Human Genetic Defect by CRISPR/Cas9-mediated Interlocus Gene Conversion

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing

Human cleaving embryos enable robust homozygotic nucleotide substitutions by base editors

Efficient Inversions and Duplications of Mammalian Regulatory DNA Elements and Gene Clusters by CRISPR/Cas9

CRISPR/Cas9 technology: applications in oocytes and early embryos

Precise Allele-Specific Genome Editing by Spatiotemporal Control of CRISPR-Cas9 Via Pronuclear Transplantation

Evaluation of guide-free Cas9-induced genomic damage and transcriptome changes in pig embryos

Limitations of gene editing assessments in human preimplantation embryos

GENE CONVERSION IN HUMAN EMBRYOS INDUCED BY GENE EDITING.

Effective Gene Editing by High-Fidelity Base Editor 2 in Mouse Zygotes

Promoting Cas9 Degradation Reduces Mosaic Mutations in Non-Human Primate Embryos

Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing

CRISPR/Cas9 Genome Editing: A Promising Tool For Therapeutic Applications of Induced Pluripotent Stem Cells.

A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells